FDA Inspection 554921 — Apotex, Inc.

Apotex, Inc. — FEI 3002808376

The FDA completed an inspection of Apotex, Inc. on Dec 19, 2008 in Etobicoke. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Dec 19, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Etobicoke (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.